Trump treated with experimental antibody cocktail for COVID-19

FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid/File Photo

(Reuters) - President Donald Trump has been treated with an experimental antibody cocktail for COVID-19 and is moving to a military hospital as a precautionary measure, White House officials said on Friday.

The president's physician, Dr. Sean Conley, said in a statement that Trump "remains fatigued but in good spirits" after receiving an intravenous dose of Regeneron Pharmaceuticals Inc's dual antibody. Trump was also taking immune system boosters zinc and vitamin D, aspirin, and other generic drugs.